National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention

Sexually Transmitted Disease Surveillance 2014 Division of STD Prevention

Chancroid — Reported Cases by Year, United States, 1981– Fig 47. SR Pg 45

Human Papillomavirus — Cervicovaginal Prevalence of High-Risk and Low-Risk Types Among Women Aged 14–59 Years by Age Group, National Health and Nutrition Examination Survey, 2003–2006 *HPV = human papillomavirus. NOTE: Error bars indicate 95% confidence interval. Both high-risk and low-risk HPV types were detected in some females. SOURCE: Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003–2006. J Infect Dis 2011;204(4):566– Fig 48. SR Pg 45

Human Papillomavirus — Cervicovaginal Prevalence of Types 6, 11, 16 and 18 Among Women Aged 14–59 Years by Age Group and Time Period, National Health and Nutrition Examination Survey, 2003–2006 and 2007–2010 NOTE: Error bars indicate 95% confidence interval. SOURCE: Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis 2013;208(3):385– Fig 49. SR Pg 46

Genital Warts—Initial Visits to Physicians’ Offices, United States, 1966–2013 NOTE: The relative standard errors for genital warts estimates of more than 100,000 range from 18% to 23%. SOURCE: National Disease and Therapeutic Index, IMS Health, Integrated Promotional Services™. IMS Health Report, 1966–2013. The 2014 data were not obtained in time to include them in this report Fig 50. SR Pg 46

Genital Warts—Prevalence per 1000 Person-Years Among Participants in Private Health Plans Aged 10–39 Years by Sex, Age Group, and Year, 2003–2010 SOURCE: Flagg EW, Schwartz R, Weinstock H. Prevalence of anogenital warts among participants in private health plans in the United States, 2003–2010: potential impact of human papillomavirus vaccination. Am J Public Health. 2013;103(8):1428– Fig 51. SR Pg 47

Genital Warts—Prevalence Among STD Clinic Patients by Sex, Sex of Partners, and Site, STD Surveillance Network (SSuN), 2014 *MSM=men who have sex with men; MSW=men who have sex with women only. NOTE: Includes the six jurisdictions (Baltimore, Los Angeles, New York City, Philadelphia, San Francisco and Seattle) who contributed data for all of Fig 52. SR Pg 47

Genital Herpes—Initial Visits to Physicians’ Offices, United States, 1966–2013 NOTE: The relative standard errors for genital herpes estimates of more than 100,000 range from 19% to 23%. SOURCE: National Disease and Therapeutic Index, IMS Health, Integrated Promotional Services™. IMS Health Report, 1966–2013. The 2014 data were not obtained in time to include them in this report Fig 53. SR Pg 48

Herpes Simplex Virus Type 2—Seroprevalence Among Non-Hispanic Whites and Non-Hispanic Blacks by Sex and Age Group, National Health and Nutrition Examination Survey, 1988–1994, 1999–2002, 2003–2006, and 2007–2010 NOTE: Error bars indicate 95% confidence interval. SOURCE: Fanfair RN, Zaidi A, Taylor LD, Xu F, Gottlieb S, Markowitz L. Trends in seroprevalence of herpes simplex virus type 2 among non-Hispanic blacks and non-Hispanic whites aged 14 to 49 years — United States, 1988 to Sex Transm Dis. 2013;40(11):860– Fig 54. SR Pg 48

Trichomoniasis and Other Vaginal Infections Among Women—Initial Visits to Physicians’ Offices, United States, 1966–2013 NOTE: The relative standard errors for trichomoniasis estimates range from 16% to 21% and for other vaginitis estimates range from 8% to 13%. SOURCE: National Disease and Therapeutic Index, IMS Health, Integrated Promotional Services™, IMS Health Report, 1966–2013. The 2014 data were not obtained in time to include them in this report Fig 55 SR Pg 49

Sexually Transmitted Disease Surveillance 2014 Division of STD Prevention

For more information please contact Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA Telephone: CDC-INFO ( )/TTY: Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention